Literature DB >> 28546731

Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy.

Sanjit Kumar Agrawal1, Sanjoy Chatterjee2, Indu Arun3, Rosina Ahmed1.   

Abstract

Entities:  

Year:  2016        PMID： 28546731      PMCID： PMC5427038          DOI： 10.1007/s13193-016-0606-1

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


× No keyword cloud information.
  8 in total

1.  Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer.

Authors:  Guangchao Jin; Yu Han; Cun Liu; Liansheng Chen; Butong Ding; Shijin Xuan; Xianqiang Liu; Guohui Ma; Jun Gao; Xingsong Tian
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).

Authors:  Sanjit Agrawal; Lalit Banswal; Animesh Saha; Indu Arun; Soumitra Shankar Datta; Sanjoy Chatterjee; Rosina Ahmed
Journal:  Indian J Surg Oncol       Date:  2016-04-23

Review 3.  Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

Authors:  S van de Ven; V T H B M Smit; T J A Dekker; J W R Nortier; J R Kroep
Journal:  Cancer Treat Rev       Date:  2010-12-21       Impact factor: 12.111

4.  Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

Authors:  Napa Parinyanitikul; Xiudong Lei; Mariana Chavez-MacGregor; Shuying Liu; Elizabeth A Mittendorf; Jennifer K Litton; Wendy Woodward; Amy Hong Zhang; Gabriel N Hortobagyi; Vicente Valero; Funda Meric-Bernstam; Ana M Gonzalez-Angulo
Journal:  Clin Breast Cancer       Date:  2014-10-02       Impact factor: 3.225

5.  Discordance of Estrogen & Progesterone Receptors After Neoadjuvant Chemotherapy in Breast Cancer- an Indian Study.

Authors:  Aravindh Sivanandan Anand; Sandeep Thekoot Velayudhan
Journal:  Indian J Surg Oncol       Date:  2016-02-25

Review 6.  Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.

Authors:  John W Cassidy; Carlos Caldas; Alejandra Bruna
Journal:  Cancer Res       Date:  2015-07-15       Impact factor: 12.701

7.  Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?

Authors:  Sanjoy Chatterjee; Animesh Saha; Indu Arun; Sonali Susmita Nayak; Subir Sinha; Sanjit Agrawal; Mayur Parihar; Rosina Ahmed
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-12-10

Review 8.  Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment.

Authors:  Xiao-xiao Sun; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2015-09-21       Impact factor: 6.150
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.